beta-alanine has been researched along with brefeldin a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezu, L; Durand, S; Forveille, S; Gomes-da-Silva, LC; Iribarren, K; Kepp, O; Kroemer, G; Leduc, M; Liu, P; Marabelle, A; Müller, K; Rekdal, Ø; Sauvat, A; Souquere, S; Yamazaki, T; Zhao, L; Zhou, H; Zitvogel, L | 1 |
1 other study(ies) available for beta-alanine and brefeldin a
| Article | Year |
|---|---|
The oncolytic compound LTX-401 targets the Golgi apparatus.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta-Alanine; Brefeldin A; Cell Line, Tumor; Golgi Apparatus; Humans; Mice, Inbred C57BL; Mitochondria; Mitochondrial Membranes; Oligopeptides; Permeability; Subcellular Fractions | 2016 |